Citation Impact
Citing Papers
The Mechanism of Action of Antitumor Platinum Compounds
1979
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Binding Characteristics of (–)‐(R)‐2‐Aminomethylpyrrolidine(1,1‐cyclobutanedi‐carboxylato)‐2‐platinum(II) to DNA, RNA and Protein Molecules in HeLa Cells and Its Lethal Effect: Comparison with cis‐ and trans‐Diammmedichloroplatinums(II)
1994
Effect of bis(bilato)-1,2-cyclohexanediammineplatinum(II) complexes on lung metastasis of B16-F10 melanoma cells in mice
1990
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
2011 Standout
Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles
2004
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
1998 Standout
Advances in platinum cancer chemotherapy
1988
Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality
1990 StandoutNobel
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Synthesis and hydrolysis studies of novel glyco-functionalized platinum complexes
2011
Phase I — Preliminary phase II trial of iproplatin, a cisplatin analogue
1988
Biodegradable polymeric nanoparticles based drug delivery systems
2009 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
2005
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
2008 Standout
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel
1996
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Platinum‐based anticancer agents: Innovative design strategies and biological perspectives
2003
Tumour-inhibiting platinum complexes—state of the art and future perspectives
2003
Cisplatin: The first metal based anticancer drug
2019 Standout
Antitumor activity and tissue distribution of bis(bilato)-1,2-cyclohexanediammineplatinum(II) complexes in BDF1 mice with murine reticulum cell sarcoma (M5076)
1993
Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data
1989
The interaction of cisplatin and analogues with DNA in reconstituted chromatin
2002
Structure and function of “metalloantibiotics”
2003
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer
2003 Standout
Platinum complex-DNA interactions and anticancer activity
1978
Preparation and Characterization of Noveltrans-[PtCl2(amine)(isopropylamine)] Compounds: Cytotoxic Activity and Apoptosis Induction inras-Transformed Cells
1999
Two Faces of Vitamin C—Antioxidative and Pro-Oxidative Agent
2020
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
New Cisplatin Analogues—On the Way to Better Antitumor Agents
1987
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Challenges for Metals in Medicine: How Nanotechnology May Help To Shape the Future
2013
Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
1986 StandoutNobel
Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia.
1977
Action mechanism of ABC excision nuclease on a DNA substrate containing a psoralen crosslink at a defined position.
1986 StandoutNobel
High-performance liquid chromatographic separation of platinum complexes containing the cis-1,2-diaminocyclohexane carrier ligand
1986 StandoutNobel
Second-sphere co-ordination of carboplatin and rhodium complexes by cyclodextrins (cyclomalto-oligosaccharides)
1989 StandoutNobel
Organometallic Anticancer Compounds
2010 Standout
Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells.
1991 StandoutNobel
The coordination chemistry of platinum anticancer drugs and related compounds with DNA
1990
The effect of combined treatment with a platinum complex and ionizing radiation on chinese hamster ovary cells in vitro
1976
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
The nature of cis amine Pd(II) and antitumor cis amine Pt(II) complexes in aqueous solutions
1976
Current status of trans-platinum compounds in cancer therapy
2001
Platinum(IV) antitumour compounds: their bioinorganic chemistry
2002
Additions to Metal-Activated Organonitriles
2002 Standout
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Charles F. Kettring prize. Fundamental studies with cisplatin
1985
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Metal-ion mediated deoxygenation of sulfoxides
1995
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Physical studies on the binding of cis-dichlorodiamine platinum(II) to DNA and homopolynucleotides
1975
Anti-tumour platinum complexes : relationships between chemical properties and activity
1978
Recent Advances in Polyoxometalate-Catalyzed Reactions
2015 Standout
Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
2014
Interactions between mammalian cell DNA and inorganic platinum compounds—I
1974
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Interaction of cis- and trans-dichlorodiammineplatinum(II) with synthetic polydeoxyribonucleotides: Effect on equilibrium buoyant densities
1977
Repair of cis-platinum-DNA adducts by ABC excinuclease in vivo and in vitro
1985 StandoutNobel
Ruthenium(II) Arene Anticancer Complexes with Redox-Active Diamine Ligands
2009
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Kinetics of formation and disappearance of a DNA cross-linking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloroplatinum(II).
1978 StandoutNobel
Chemical reactivity of monofunctional platinum-DNA adducts
1986
Thiourea Reverses Cross-Links and Restores Biological Activity in DNA Treated with Dichlorodiaminoplatinum(II)
1979 StandoutScienceNobel
Cis-diamminedichloroplatinum (II)
1977
100 years of metal coordination chemistry: from Alfred Werner to anticancer metallodrugs
2014
Cyclodextrins as second‐sphere ligands for transition metal complexes
1988 StandoutNobel
Inhibition by caffeine of post-replication repair in Chinese hamster cells treated with cis platinum (II) diamminedichloride: The extent of platinum binding to template DNA in relation to the size of low molecular weight nascent DNA
1976
Platinum coordination compounds with potent anticancer activity
2017
The influence of structure on the activity and toxicity of Pt anti-cancer drugs
1997
Works of P.D. Braddock being referenced
Entering group, leaving group, and cis effects of alicyclic primary amines in substitution reactions of platinum(II) complexes containing sulfur-bonded dimethyl sulfoxide
1974
New platinum complexes with anti-tumour activity
1972
Structure and activity relationships of platinum complexes with anti-tumour activity
1975